MARKET

VCNX

VCNX

Vaccinex Inc
OTCPK
1.030
-0.170
-14.17%
Closed 12:48 02/06 EST
OPEN
1.200
PREV CLOSE
1.200
HIGH
1.200
LOW
1.030
VOLUME
211
TURNOVER
253
52 WEEK HIGH
1.500
52 WEEK LOW
0.249
MARKET CAP
2.76M
P/E (TTM)
-0.1160
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VCNX last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at VCNX last week (0119-0123)?
Weekly Report · 01/26 10:15
Weekly Report: what happened at VCNX last week (0112-0116)?
Weekly Report · 01/19 10:21
Weekly Report: what happened at VCNX last week (0105-0109)?
Weekly Report · 01/12 10:20
Weekly Report: what happened at VCNX last week (1229-0102)?
Weekly Report · 01/05 10:14
Weekly Report: what happened at VCNX last week (1222-1226)?
Weekly Report · 12/29/2025 10:14
Vaccinex Secures $60 Mln To Advance Enlarged Phase 2b Alzheimer's Trial
NASDAQ · 12/23/2025 14:18
Vaccinex announces $60M revenue sharing agreement with PDV
TipRanks · 12/23/2025 13:21
More
About VCNX
Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer’s disease, head and neck, pancreatic and breast cancer. Its platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. Its SEMA4D antibody platform is the application of its knowledge of SEMA4D biology to develop pepinemab for the treatment of various diseases and conditions, including neuroinflammatory and neurodegenerative diseases and cancer. It also discovered VX5 using its ActivMAb platform. VX5 is a human antibody to CXCL13, a molecule that regulates the formation of immune tissues, and is in preclinical development for the treatment of autoimmune disorders.

Webull offers Vaccinex Inc stock information, including OTCPK: VCNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCNX stock methods without spending real money on the virtual paper trading platform.